Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-06

Clinical Trial Update: Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating hydroxycitrate as a therapy for calcium phosphate kidney stones is currently recruiting. The sponsor is University of Texas So…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxycitrate (Hydroxycitrate)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Calcium Phosphate Kidney Stones | Phase 4 | Status: RECRUITING